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In this review we have summarized the results of our recent research on telomerase inhibitors and G-quadruplex
DNA ligands. A series of potential enzyme inhibitors were synthesized and studied. These compounds were ba-
sed on tricyclic heteroaromatic systems (thiazolobenzimidazoles phenazines, acridones), amino-substituted cya-
nines and natural and synthetic porphyrins and their metalocomplexes. A number of compounds, including cya-
nines and especially porphyrin derivatives and conjugates, were found to efficiently inhibit telomerase at low
micromolar concentrations in the in vitro TRAP assay. Porphyrins demonstrated antiproliferative activity in tu-
mor cell cultures at micro- and nanomolar concentrations. Spectral-fluorescent and electrophoretic experi-
ments were performed to investigate the interaction of ligands with duplex and quadruplex DNA, and in many ca-
ses binding mode was established. Convenient G-octet model of G-quadruplex was developed to study the li-
gand-target binding using quantum-chemical methods. QM/MM hybrid approach ONIUM2 was employed to mo-
del the interaction of small molecules with Tel22 quadruplex DNA.
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Inhibition of telomerase and quadruplex DNA. Qui-
te recently emerged antitumor strategy is based on the
use of small molecules that specifically target telome-
res and telomerase [1–4]. Telomeres are guanine-rich
DNA sequences localized at the ends of the chromoso-
mes. They protect chromosomal DNA from degrada-
tion, prevent end-to-end fusion and other forms of aber-
rant recombination, and allow it to be completely repli-
cated without loss of genetic material. The length of the
telomeres correlates with the ability of a cell to undergo
a large number of cell divisions. Normally telomeric
DNA is shortened by 50–200 nucleotides upon each cel-
lular division that may control the proliferative capaci-
ty of normal somatic cells. However, this does not occur
in tumor cells due to high activity of telomerase, an en-
zymewhich is responsible for maintaining the telomere
length and synthesizes the lost telomeric sequences by
adding telomeric repeats (5'-TTAGGG-3' sequence in
humans), that leads to uncontrolled proliferation. Inhi-
bition of telomerase activity induces senescence in can-
cer cells followed by their death.
In contrast, normal somatic cells are devoid of telo-
merase activity, so high level of enzyme expression is
directly associated with tumor cells. Indeed, increased
telomerase activity was de tected in 85–90 % of human
tumors [1, 3]. That’s why telomerase system is now con-
sidered a promisingmolecular target for anticancer drugs.
Telomerase is a complex highly specialized reverse
transcriptase (RT) utilizing its own RNA component
(hTR) as a template to synthesize telomeric repeats.
Current approaches to inhibit telomerase by small mole-
cules include the application of nucleoside and non-nuc-
leoside RT inhibitors, antisense oligonucleotide analo-
gues against hTR, ribozymes and siRNA [5–9]. These
approaches are rather traditional for the control of gene
expression and the inhibition of enzymes of nucleic
acids biosynthesis.
However, we have concentrated on the other possi-
bility that is based on the presence of specific structural
motifs in telomeric DNA.
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Guanine-rich DNA sequences can adopt unique
high-order structures called G-quadruplexes (G4) for-
med by stacked arrays of guanine quartets connected by
non-canonical Hoogsteen-type hydrogen bonds. These
DNA arrangements were shown to play a crucial biolo-
gical role. DNA sequences able to fold into G4 struc-
tures are prevalent in telomeres, but they have been also
found in a number of gene promoter regions, first of all
in proto-oncogenes like c-myc or k-ras [10–13].
G-quadruplexes are specific DNA structures that in-
clude planar G-quartet stacks and four grooves provi-
ding different geometries and spatial distribution of
functional groups relative to duplex DNA, so they allow
selective recognition by small molecules. The strong bin-
ding of a drug onto the telomeres inhibits telomerase,
and subsequent decrease of the telomeres length in can-
cer cells stops their proliferation. Selective quadruplex
ligands stabilizing G4 structures may disturb the bin-
ding of enzyme to telomeric DNA and block its elonga-
tion that results in anticancer activity [4, 5, 7, 10]. By
this elegant approach the enzyme inhibition is achieved
via the interaction of drugs with its substrate, telomeric
DNA, rather than telomerase itself, so they can be consi-
dered indirect enzyme inhibitors (Fig. 1).
A number of efficient quadruplex binding/stabi-
lizing ligands with anticancer properties were reported
(e. g. BRACO-19, telomestatin, BMVC, Quarfloxin).
They are usually based on heteroaromatic structures like
acridines, anthraquinones, carbazoles, macrocyclic po-
lyoxazoles, etc. [5, 7, 14–16]. Generally, stabilization
of quadruplex conformations by small molecules can
occur via the  interaction of cationic or neutral aro-
matic fragments with G-quartets (usually external sta-
cking at the terminal G-quartet) and by the electrostatic
interaction of positively charged ligands, either aroma-
tic cores or cationic or easily protonated basic substitu-
ents, with G4 DNA polyphosphate backbone [14–16].
The design of G4 ligands is mainly based on planar po-
lycyclic aromatic scaffolds able to interact with G-quar-
tets via the stacking mechanism.
Study on tricyclic heterocycles and cyanines as
telomerase inhibitors. Research on G4 binders and te-
lomerase inhibitors started at the Department of Syn-
thetic Bioregulators in 2008. Since then, we have syn-
thesized and studied dozens of heterocyclic compounds
of many classes, including the derivatives of tricyclic
systems (thiazolobenzimidazoles, phenazines, acrido-
nes), cyanines and porphyrins (Fig. 2, 3).
The inhibition of telomerase was investigated in vit-
ro using the TRAP assay (Telomeric Repeat Amplifica-
tion Protocol) that allows direct analysis of enzymatic
activity [17, 18]. It should be noted that the separation
of inhibitor from the reaction mixture after the first step
of TRAP (telomerase reaction) before PCR amplifica-
tion is crucial for obtaining correct activity data. This is
because many compounds (e. g. some acridones and
cyanines) inhibit Taq-DNA-polymerase while not affec-
ting telomerase. This may result in false-positive re-
sults in two-step TRAP assay.
2-Aryl(hetaryl)idene-substituted benzimidazothia-
zolone (1) known as potent transcription inhibitors [19]
were found to be inactive in TRAP assay.
An extensive series of phenazine, acridone and thio-
xanthone derivatives (2-3), including those with a neut-
ral benzazole fragment or basic or cationic substituent
(dimethylamino, trimethylammonium or N-methylpy-
ridinium group) at C-1 or C-4 position of heterocycles,
were prepared (Dr. V. Kostina, N. Lysenko). Tested com-
pounds were not efficient inhibitors, with rather low le-
vel of activity of some derivatives at 50–100 µM con-
centration. Perhaps this is due to both the relatively small
size of the core molecules and the presence of a single
substituent interacting with a phosphate. Now we are
working on the modification of these structures with the
second basic/cationic group. Indeed, efficient tricyclic
G4 ligands usually contain at least two substituents of
this type [5, 7, 14–16].
A number of 2-amino-substituted cyanines (4), struc-
tural analogs of Thiazole Orange dye, were then obtai-
ned (Dr. D. Kryvorotenko). These compounds contain
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Fig. 1. Mechanism of telomerase inhibition by G-quadruplex ligands
rather large aromatic fragment, along with a basic sub-
stituent. The size and structure of aromatic core with a
delocalized positive charge allows its efficient  in-
teraction with two guanine residues of G-quartet. These
derivatives demonstrated quite high inhibitory activity
in the TRAP assay. Five compounds were found to inhi-
bit telomerase at 40 µM concentration. At lower con-
centrations the effect decreased, however, two com-
pounds were still able to completely inhibit enzyme at
20 µM. Cyanine with 2-methylbenzylamino substituent
demonstrated significant activity at 10 µM. So, cyanines
appeared to be active telomerase inhibitors at micromo-
lar concentrations.
On the other hand, some cyanines were found to in-
hibit also Taq-DNA-polymerase at 10 µM concentra-
tion. Spectral-fluorescent studies and electrophoretic
experiments revealed the strong binding of cyanines to
duplexDNA to formhighly fluorescent complexes. Thus,
cyanines have a good potential as telomerase inhibitors,
however, their structures require further optimization to
increase inhibitory activity and selectivity to telomera-
se and quadruplex over duplex DNA.
Porphyrin derivatives and their interaction with
DNA. G-quartet consists of four guanine bases, so its
square is twice as large as the square of the base pair.
Due to this large area of G-quartet, a specific quadrup-
lex binder should have a large aromatic/heteroaromatic
surface, larger than that required for duplex ligands.
Only in this case G4 ligand would provide an efficient
overlap with its target and good quadruplex selectivity
over the duplex DNA [7, 14, 15]. Although molecular
modeling demonstrated the ability of our tricyclic com-
pounds to bind to quadruplex DNA, these molecules
seem to be too small for the efficient  stacking with
G-quartets. From this point of view, large porphyrin li-
gands may be preferable as their molecules perfectly
overlap with G-quartets. Moreover, the porphyrins are
selectively taken up by tumor cells, so the design of por-
phyrin-based anticancer drugs is a promising strategy
in medicinal chemistry.
We have thus synthesized a series of derivatives of
the natural porphyrin Pheophorbide-a and synthetic tri-
cationic porphyrin TMP3 (Fig. 3). They have indeed de-
monstrated an efficient binding to G4DNA, telomerase
inhibition and good antiproliferative activity.
Pheophorbide-a (5a, Pheo-a) is currently used in
photodynamic therapy of tumors. However, its anionic
character prevents its interaction with nucleic acids,
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and water solubility of (5a) and its methyl ester (5b) is
low. Cationic derivative of labile Pheo-a containing tri-
methylammonium group on a short linker (5c, CatPheo-
a) was obtained for the first time to improve both the
solubility and DNA binding affinity.
CatPheo-a interaction with double-stranded poly
(A)poly(U), poly(G)poly(C) and four-stranded poly(G)
was studied by absorption and fluorescence spectrosco-
py techniques in a wide range of molar phosphate-to-
dye ratios (P/D) [20]. Two types of binding were revea-
led: dye intercalation between the nucleic bases and ex-
ternal cooperative binding via the electrostatic interac-
tion of the dye to polynucleotide backbones. The last ty-
pe is predominant for double-stranded polynucleoti-
des. In the case of four-stranded poly(G), the external
binding prevails at P/D < 5, whereas under high P/D va-
lues the intercalative binding is mainly realized which
is accompanied with 4.5-fold fluorescence enhance-
ment. Electrostatic interaction with nucleic acids was
investigated on amodel (5c)–polyphosphate system [21].
To study the intercalative type of Pheo-a binding in
its pure form we have used its neutral methyl ester (5b,
MePheo-a) [22]. Substantial spectral changes, including
the 50-fold increase of dye emission intensity, eviden-
ce its intercalation into four-stranded structures. In con-
trast, the binding to double-stranded polynucleotides
and native DNA is accompanied by insignificant spect-
ral transformations, with no more than 4-fold fluores-
cence enhancement, due to incorporation of (5b) into a
double helix groove, presumably, in the dimeric form.
Since the binding ofMePheo-a to quadruplex DNA
induces great increase of fluorescence, this dye, and to
a lesser extent (5c), is a good fluorescent probe for mo-
nitoring G4 structures. Currently we are studying the ef-
fect of these compounds on telomerase activity.
A number of cationic porphyrins, including exten-
sively studied tetra-(4-N-methylpyridinium)porphine
(TMPyP4), have been identified as G4-interactive
agents that inhibit telomerase (see reviews [5, 7, 14,
16]). TMP3 is a tricationic analog of TMPyP4 suitable
for the conjugation to other molecules, e. g. oligonuc-
leotides [23–25]. To increase the affinity of porphyrin
to G4 DNA it was proposed to link TMP3 to aminoqui-
noline intercalating agent [26].
We have obtained and studied a series of TMP3 de-
rivatives (Fig. 3). For the first time, TMP3 was cova-
lently attached to imidazo[4,5-d]phenazine (ImPhz).
Previously we have shown that N1-riboside of this dye is
an intercalating agent efficiently stabilizing duplex and
triplex DNA [27, 28], and oligonucleotides containing
this nucleoside inhibit transcription and translation in
mollicutes [29]. A non-nucleoside ImPhz derivative sui-
table for conjugation reactions was developed, and in-
corporation of this group into oligonucleotides was
shown to stabilize complementary DNA duplexes via
the intercalation mechanism [30, 31]. It was expected
that porphyrin fragment of the conjugate (7) would sta-
bilize G-quartets, whereas ImPhz group could enhance
the affinity by intercalating into double-stranded region
of telomeric DNA, or between G-quartets. So TMP3-
imidazophenazine conjugates (7a, b) with different lin-
kers and their Zn(II) and Mn(III) complexes were obtai-
ned [32]. Trimethylammonium group was introduced
into (6b) for additional binding to the phosphates.
The interaction of TMP3 (6a) with polynucleotides
and quadruplex-forming oligonucleotide Tel22 (22-mer
sequence d[AGGG(TTAGGG)3] of human telomere)
was investigated by spectroscopic methods [33]. Three
types of competitive binding mechanisms were revealed
which are characterized by different changes in spectral
parameters: (i) intercalation of the porphyrin between
nucleic bases, (ii) its embedding into polynucleotide
grooves, and (iii) external stacking-association on po-
lyanionic backbone. At low P/D the last mechanism is
dominating. It was modeled by the dye binding to inor-
ganic polyphosphate, where the self-assembly of (6a)
with a formation of J- and H-aggregates was establi-
shed. Molecular modeling provided the structures of ag-
gregates formed by TMP3molecules arranged in paral-
lel or antiparallel mode [34].
Spectral characteristics of TMP3-ImPhz and its Zn
complex (e. g. fluorescence quenching of both dyes)
evidence the formation of internal heterodimers with
stacking between porphyrin and phenazine rings. In the
case of Mn-TMP3-ImPhz it has not occurred, perhaps
due to the coordination of two axial water ligands by
Mn3+ ion. Quantum-chemical study of the conjugates (7)
by DFT (Density Functional Theory) method confirmed
possible formation of intramolecular complexes where
ImPhz directly interacts with a porphyrin. Two structu-
res are realized depending on the presence of metal ca-
tion in a porphyrin ring (Fig. 4). Non-metalated hybrid
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adopts the conformation with coplanar chromophores
stabilized by stacking (A). For Zn derivative, the metal
coordination with a nitrogen atom of ImPhz fragment
results in the formation of the other type of complex
(B). The folding of linear conjugate is energetically ve-
ry favorable. For example, G298 of this process for Zn-
(7b) in vacuum and water is 15.61 and 12.34 kcal/mol,
respectively. Thus, the solvent does not significantly
affect the formation of heterodimer; the structure of the
linker between chromophores has quite limited effect
as well [32].
Studies on the interaction of conjugates (7) with in-
termolecular G-quadruplex formed by poly(G) revea-
led that both dyes bind to the polynucleotide. The por-
phyrin moiety forms complexes of two types with G4
structure. Under low P/D values the outside binding ac-
companied by the stacking-association of porphyrin
molecules along the polynucleotide backbone takes pla-
ce (with the exception of Mn-TMP3-ImPhz) It succes-
sfully competes with another interaction mode which
becomes dominant under high P/D, namely the nonin-
tercalative binding, evidently by insertion of the por-
phyrins into poly(G) groove. The phenazine part of all
hybrids binds to polynucleotide by intercalation [35].
The interaction of conjugates and their metal comp-
lexes with intramolecular G-quadruplex Tel22 was al-
so studied [36]. All the hybrids have high binding affi-
nity to the quadruplex, probably via the external groove
binding of the porphyrin. Small emission of Mn-TMP3
increases ca. 20-fold upon the binding. It was found that
Zn- and Mn-TMP3-ImPhz stabilize G4 structure increa-
sing its melting point by 3 oC, whereas non-metalated
hybrid decreases it by ca. 2 oC. In the case of metal com-
plexes, 10-fold increase in the Tel22 folding equilibrium
constant at 37 oC was determined, so these compounds
quite efficiently stabilize the quadruplex structures.
Biological activity of porphyrin derivatives. The
effect of porphyrins on telomerase activity was evalua-
ted in the TRAP assay [37]. All of them inhibited telo-
merase at micromolar concentrations. Almost complete
inhibition was achieved with TMP3 methyl ester (6a)
and TMP3-ImPhz (7a), as well as with TMPyP4, at
6 µM concentration. It is interesting to note that the ac-
tivity of (7a) at 12 µMwas lower than that at 6 µM, per-
haps due to the aggregation at higher concentrations. As
expected, compound (6b) containing phosphate-bin-
dingMe3N
+ group appeared to be several times more ac-
tive and efficiently inhibited the telomerase at 2 µM.
Zinc complex of the conjugate was the most active com-
pound almost completely inhibiting the enzyme at 1 µM
concentration. Mn(III) complex was less active.
Thus, TMP3 derivatives are potent telomerase inhibi-
tors in vitro. Two of them are comparable to TMPyP4
standard, whereas cationic derivative (6b) and Zn(II)
complex ofTMP3-ImPhz conjugate aremuchmore active.
Antiproliferative activity of several TMP3 derivati-
ves was investigated in vitro. TMP3 conjugate (7a) and
its Zn(II) complex, as well as compounds (6a) and (6b),
were tested in the cultures of human tumor cells HeLa
and MCF-7 (MTT assay). The last two compounds de-
monstrated EC50 values in the range 6–8 µM on HeLa
cells, whereas MCF-7 cells were more susceptible to
these drugs (EC50 0.2–0.7 µM). Conjugates were more
active, with EC50 0.1–0.4 µM for non-metalated hyb-
rid (7a). At the same time, its Zn(II) complex demonst-
rated very high activity in HeLa cell culture (EC50 as low
as 20 nM).
It should be noted that antiproliferative activity of
TMP3 derivatives correlates well with the data on telo-
merase inhibition obtained in the TRAP assay.
TMP3-ImPhz hybrids (7b) were tested on mouse
Lewis lung carcinoma cells (LLC line) [32]. This line of
tumor cells was in part selected since they can be grafted
in mice, so it is a good model for in vivo experiments. In-
corporation of [3H]-thymidine was used for the quantita-
tive analysis. All the conjugates demonstrated good an-
tiproliferative activity, and metal complexes were seve-
ral times more active than non-metalated hybrid. Expe-
rimental EC50 values for non-metalated (7b), its Mn and
Zn complex were 21.8, 11.2 and 5.9 µM, respectively.
These values are comparable to those of known antican-
cer drugs doxorubicin and vincristine. So the conjugates
of G4 ligand TMP3, especially their metal complexes,
efficiently suppress LLC mouse tumor cells in vitro.
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Fig. 4. DFT structures of the conjugate 7b (A) and its Zn(II) complex (B)
Molecular modeling in the study of telomerase
inhibitors. Computer modeling of the structures of G4
ligands and their interaction with G-quadruplexes was
always an integral part of our research. The availability
of crystallographic and NMR data for G4 structures [10,
12] allows the development of new antitumor drugs
using computational methods. Modeling was based on
quantum chemistry approaches, rather than docking or
molecular dynamics common for drug design. Both semi-
empirical and non-empirical methods were employed.
First, a comprehensive analysis of G-quadruplex struc-
tures was carried out. Studies on G-quartets and G-oc-
tets as structural elements of G-quadruplexes were per-
formed in vacuum and in aqueous medium [38]. Guani-
ne quartets in vacuum were found to have not only the
Hoogsteen or bifurcated, but also a mixed system of
hydrogen bonds; in water the latter two forms are easily
transformed into the classic Hoogsteen structure. For
G-octets, four stable configurations with D4, C4 and S4
symmetry formed by the pairs of guanine quartets with
Hoogsteen, bifurcated or mixed H-bonds were identi-
fied. Most important, S4-structure consisting of the pair
of mixed Hoogsteen-bifurcated type G-quartets was
shown to be the most advantageous structure of G-octet
in water.
We have proposed G-octet, a pair of G-quartets sta-
bilized by  interactions and containing a K
+ or NH4+
cation located between the quartet planes, as a simple
model of natural G-quadruplexes (consisting usually of
three or four G-quartets) suitable for the calculations of
G4-ligand binding energies and complex geometries
[38]. It was used e. g. to model TMP3-ImPhz binding to
G4: it was found that phenazine moiety can interact
with a surface of porphyrin ring or G-quartet, but its in-
tercalation between G-quartets is less favorable. It was
shown for many types of compounds that the calculated
energies of interaction with G-octets correlated with
their biological activity.
For the calculations of more complex molecular sys-
tems we have successfully applied a hybrid QM/MM
(quantummechanics – molecular mechanics) approach
ONIOM2 [39]. This method combines high accuracy
QM calculations in the spatially restricted functionally
important region of the system (high layer) with less ac-
curate, but much faster MM calculations in the remai-
ning part (low layer). It was employed to model the in-
teraction of small molecules with full-size Tel22 quad-
ruplex (PDB code 1KF1). This method is suitable for
charged ligands able to interact with phosphates, for
which G-octet model cannot provide correct binding
data (Fig. 5).
ONIOM modeling allows finding optimal structu-
res of G4-ligand complexes and determining binding
energies. It also provides valuable information on pos-
sible structural modification of the ligands to improve
their binding efficiency, e. g. linker length and structu-
re, number and orientation of the substituents, etc. For
example, it is clear from Fig. 5 that the introduction of
the second cationic group on an appropriate linker into
acridone structure Awould result in the increase of bin-
ding energy due to its interaction with the second phos-
phate group.
Conclusion. The aim of our research is to find effi-
cient G4 ligands that would be able at the same time to
discriminate between different forms of nucleic acids in
order to be specific for telomeric DNA. The binding of
small molecules to G4 DNA and their activity as telo-
merase inhibitors depend on the size, shape and charge
of the central aromatic ring, the nature of its substi-
tuents and electronic density distribution in the mole-
cule. Efficient G4-ligands should contain planar aro-
matic areas that bind to G-quartets. However, the size of
trcyclic molecules seems to be just insufficient to ensure
the highest affinity interaction with large G-quartets,
although this can be compensated by the substituents
binding to phosphate anions; perhaps in the case of
tricyclic ligands one substituent of cationic character is
not sufficient for strong G4-ligand binding. Cyanines
containing both cationic aromatic core able to overlap
with two guanine residues and a basic substituent
appeared to be much more efficient. At the same time,
molecular and electronic structure of porphyrins allows
them to match perfectly large planar surfaces of
G-quartets.
The future research will be directed at increasing
the affinity and selectivity of telomerase inhibitors for
quadruplex DNA. Most G4 binders contain intercala-
ting fragments and thus are not specific exclusively to
quadruplex over duplex DNA that may result in non-
specific cytotoxicity. There is a number of ways to in-
crease a quadruplex specificity of small molecules and
their binding constants. Optimization of the core aro-
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matic fragments would result in favorable ligand inter-
action with G-quartet. The introduction of structural
moieties, binding in a specific manner to G4 grooves
whose structural features differ from those in duplex
DNA, or fragments able to interact with the loops of G4
structures, could provide additional contacts with quad-
ruplex elements. These modifications would lead to
strong and specific binding of synthetic molecules to
quadruplexDNAand efficient inhibition of telomerase.
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Äèçàéí ³ âèâ÷åííÿ ³íã³á³òîð³â òåëîìåðàçè íà îñíîâ³ ë³ãàíä³â
G-êâàäðóïëåêñ³â
Ðåçþìå
Â îãëÿä³ ï³äñóìóâàíî îñíîâí³ ðåçóëüòàòè íàøèõ íåäàâí³õ äîñë³ä-
æåíü ³íã³á³òîð³â òåëîìåðàçè òà ë³ãàíä³â G-êâàäðóïëåêñíî¿ ÄÍÊ.
Ñèíòåçîâàíî é âèâ÷åíî ñåð³þ ïîòåíö³éíèõ ³íã³á³òîð³â ôåðìåíòó
íà îñíîâ³ òðèöèêë³÷íèõ ãåòåðîàðîìàòè÷íèõ ñèñòåì (ò³àçîëîáåíç-
³ì³äàçîëè, ôåíàçèíè, àêðèäîíè), àì³íîçàì³ùåíèõ ö³àí³í³â òà ïðè-
ðîäíèõ ³ ñèíòåòè÷íèõ ïîðô³ðèí³â ³ ¿õí³õ ìåòàëîêîìïëåêñ³â. Çíàé-
äåíî íèçêó ñïîëóê – ö³àí³í³â òà îñîáëèâî ïîõ³äíèõ ³ êîí’þãàò³â
ïîðô³ðèí³â, ùî åôåêòèâíî ³íã³áóþòü òåëîìåðàçó in vitro çà óìîâ
òåñòó TRAP ó ì³êðîìîëÿðíèõ êîíöåíòðàö³ÿõ. Ïîðô³ðèíè ó ì³êðî-
òà íàíîìîëÿðíèõ êîíöåíòðàö³ÿõ äåìîíñòðóþòü àíòèïðîë³ôåðà-
òèâíó ä³þ â êóëüòóðàõ ïóõëèííèõ êë³òèí. Ñïåêòðîôëóîðåñöåíòíè-
ìè òà åëåêòðîôîðåòè÷íèìè ìåòîäàìè äîñë³äæåíî âçàºìîä³þ
ë³ãàíä³â ç äóïëåêñíîþ òà êâàäðóïëåêñíîþ ÄÍÊ, ó áàãàòüîõ âèïàä-
êàõ âèçíà÷åíî òèï çâ’ÿçóâàííÿ. Âçàºìîä³þ ë³ãàíä–ì³øåíü âèâ÷åíî
ìåòîäàìè êâàíòîâî¿ õ³ì³¿ çà âèêîðèñòàííÿ G-îêòåòó ÿê çðó÷íî¿
ìîäåë³ G-êâàäðóïëåêñó. Äëÿ ìîäåëþâàííÿ çâ’ÿçóâàííÿ ìàëèõ ìîëå-
êóë ç êâàäðóïëåêñíîþ ÄÍÊ Tel22 çàñòîñîâàíî ã³áðèäíèé QM/MM-
ï³äõ³ä ONIOM2.
Êëþ÷îâ³ ñëîâà: òåëîìåðàçà, G-êâàäðóïëåêñ, TRAP, ïðîòèïóõ-
ëèíí³ çàñîáè, ïîðô³ðèíè, ìîëåêóëÿðíå ìîäåëþâàííÿ.
Â. Â. Íåãðóöêàÿ, Ë. Â. Äóáåé, Í. Í. Èëü÷åíêî, È. ß. Äóáåé
Äèçàéí è èññëåäîâàíèå èíãèáèòîðîâ òåëîìåðàçû íà îñíîâå
ëèãàíäîâ G-êâàäðóïëåêñîâ
Ðåçþìå
Â îáçîðå ñóììèðîâàíû îñíîâíûå ðåçóëüòàòû íàøèõ íåäàâíèõ èñ-
ñëåäîâàíèé èíãèáèòîðîâ òåëîìåðàçû è ëèãàíäîâ G-êâàäðóïëåêñ-
íîé ÄÍÊ. Ñèíòåçèðîâàíà è èçó÷åíà ñåðèÿ ïîòåíöèàëüíûõ èíãèáè-
òîðîâ ôåðìåíòà íà îñíîâå òðèöèêëè÷åñêèõ ãåòåðîàðîìàòè÷åñêèõ
ñèñòåì (òèàçîëîáåíçèìèäàçîëû, ôåíàçèíû, àêðèäîíû), àìèíî-çà-
ìåùåííûõ öèàíèíîâ, ïðèðîäíûõ è ñèíòåòè÷åñêèõ ïîðôèðèíîâ è
èõ ìåòàëëîêîìïëåêñîâ. Îáíàðóæåí ðÿä ñîåäèíåíèé – öèàíèíîâ è
îñîáåííî ïðîèçâîäíûõ è êîíúþãàòîâ ïîðôèðèíîâ, ýôôåêòèâíî èí-
ãèáèðóþùèõ òåëîìåðàçó in vitro â óñëîâèÿõ òåñòà TRAP â ìèêðî-
ìîëÿðíûõ êîíöåíòðàöèÿõ. Ïîðôèðèíû â ìèêðî- è íàíîìîëÿðíûõ
êîíöåíòðàöèÿõ äåìîíñòðèðóþò àíòèïðîëèôåðàòèâíîå äåéñò-
âèå â êóëüòóðàõ îïóõîëåâûõ êëåòîê. Ñïåêòðîôëóîðåñöåíòíûìè è
ýëåêòðîôîðåòè÷åñêèìè ìåòîäàìè èññëåäîâàíî âçàèìîäåéñòâèå
ëèãàíäîâ ñ äóïëåêñíîé è êâàäðóïëåêñíîé ÄÍÊ, âî ìíîãèõ ñëó÷àÿõ
îïðåäåëåí òèï ñâÿçûâàíèÿ. Âçàèìîäåéñòâèå ëèãàíä–ìèøåíü èçó-
÷åíî ìåòîäàìè êâàíòîâîé õèìèè ñ èñïîëüçîâàíèåì G-îêòåòà êàê
óäîáíîé ìîäåëè G-êâàäðóïëåêñà. Äëÿ ìîäåëèðîâàíèÿ ñâÿçûâàíèÿ
ìàëûõ ìîëåêóë ñ êâàäðóïëåêñíîé ÄÍÊ Tel22 ïðèìåíåí ãèáðèäíûé
QM/MM-ïîäõîä ONIOM2.
Êëþ÷åâûå ñëîâà: òåëîìåðàçà, G-êâàäðóïëåêñ, TRAP, ïðîòèâî-
îïóõîëåâûå ñðåäñòâà, ïîðôèðèíû, ìîëåêóëÿðíîå ìîäåëèðîâàíèå.
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